Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 15, 2016 13:21 ET | Source: COTA, Inc.

Guardant Health® and COTA Partner to Explore the Costs, Benefits, and Barriers of Genotyping Patients with Advanced Lung Cancer with a Non-invasive Liquid Biopsy

NEW YORK, March 15, 2016 (GLOBE NEWSWIRE) -- COTA Inc. and Guardant Health have partnered to provide new insights into the barriers to obtaining genomic profiling of driver mutations among patients...